Medpace Holdings Inc (NAS:MEDP)
$ 389.82 -6.83 (-1.72%) Market Cap: 12.08 Bil Enterprise Value: 12.02 Bil PE Ratio: 39.74 PB Ratio: 17.99 GF Score: 94/100

Medpace Holdings Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 03:35PM GMT
Release Date Price: $70.87 (+1.13%)
Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

Good morning, everybody. My name is Erin Wright. I cover life sciences diagnostic tools at Crédit Suisse, and welcome to our CS Healthcare Conference here in Scottsdale. We're happy to have Medpace with us today. We have Jesse Geiger, the CFO; as well as the CEO, August Troendle, as well, that hopefully, they can give us an update on what's going on in the CRO market. With that, we do have a fireside chat setting, but please feel free to reach out or raise a hand if you do have questions. You can always email me if you would like to anonymously put out a question. That's totally fine with me.

Questions & Answers

Erin Elizabeth Wilson Wright;dit Suisse AG
CrÃ;Research Division - Director & Senior Equity Research Analyst

© -

But we'll get started here. Can you give us a sense of where we stand today with the overall RFP environment? What we saw kind of in the most recent quarter? You

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot